Mirjam Langeveld

2.4k total citations
78 papers, 1.5k citations indexed

About

Mirjam Langeveld is a scholar working on Physiology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Mirjam Langeveld has authored 78 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Physiology, 29 papers in Molecular Biology and 23 papers in Clinical Biochemistry. Recurrent topics in Mirjam Langeveld's work include Lysosomal Storage Disorders Research (36 papers), Metabolism and Genetic Disorders (23 papers) and Diet and metabolism studies (11 papers). Mirjam Langeveld is often cited by papers focused on Lysosomal Storage Disorders Research (36 papers), Metabolism and Genetic Disorders (23 papers) and Diet and metabolism studies (11 papers). Mirjam Langeveld collaborates with scholars based in Netherlands, United Kingdom and United States. Mirjam Langeveld's co-authors include Carla E. M. Hollak, Johannes M. F. G. Aerts, André B. P. Kuilenburg, J.E.M. Groener, J. Hans DeVries, Ivo N. van Schaik, Janneke G. Langendonk, Maaike de Fost, Frits A. Wijburg and Mireille J. Serlie and has published in prestigious journals such as American Journal of Clinical Nutrition, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mirjam Langeveld

75 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mirjam Langeveld Netherlands 23 872 612 330 316 199 78 1.5k
Tim Wood United States 21 563 0.6× 594 1.0× 302 0.9× 248 0.8× 141 0.7× 61 1.3k
Klary E. Niezen‐Koning Netherlands 22 930 1.1× 709 1.2× 196 0.6× 367 1.2× 243 1.2× 59 1.8k
Enzo Ranieri Australia 23 486 0.6× 385 0.6× 138 0.4× 165 0.5× 115 0.6× 55 1.5k
Adolf Mühl Austria 20 503 0.6× 382 0.6× 399 1.2× 140 0.4× 127 0.6× 44 1.4k
Haruo Shintaku Japan 25 698 0.8× 777 1.3× 138 0.4× 350 1.1× 85 0.4× 116 2.1k
Amel Karaa United States 24 394 0.5× 745 1.2× 145 0.4× 289 0.9× 41 0.2× 65 1.5k
Joe T.R. Clarke Canada 32 1.5k 1.7× 1.1k 1.9× 584 1.8× 524 1.7× 409 2.1× 109 2.8k
Misao Ōwada Japan 19 470 0.5× 343 0.6× 216 0.7× 140 0.4× 130 0.7× 70 1.3k
Klaus Gempel Germany 17 451 0.5× 825 1.3× 70 0.2× 96 0.3× 82 0.4× 30 1.5k
Deborah Marsden United States 24 532 0.6× 854 1.4× 175 0.5× 91 0.3× 50 0.3× 65 1.8k

Countries citing papers authored by Mirjam Langeveld

Since Specialization
Citations

This map shows the geographic impact of Mirjam Langeveld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjam Langeveld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjam Langeveld more than expected).

Fields of papers citing papers by Mirjam Langeveld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjam Langeveld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjam Langeveld. The network helps show where Mirjam Langeveld may publish in the future.

Co-authorship network of co-authors of Mirjam Langeveld

This figure shows the co-authorship network connecting the top 25 collaborators of Mirjam Langeveld. A scholar is included among the top collaborators of Mirjam Langeveld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirjam Langeveld. Mirjam Langeveld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Langeveld, Mirjam, et al.. (2025). Metabolic cardiomyopathies: untangling clinical heterogeneity with human stem-cell derived models. EMBO Molecular Medicine. 17(11). 2853–2874.
2.
Cretenet, Gaspard, Bauke V. Schomakers, Michel van Weeghel, et al.. (2025). Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia. Cellular and Molecular Immunology. 22(5). 485–500. 4 indexed citations
3.
Langeveld, Mirjam, Sandra Sirrs, Timothy Fazio, et al.. (2025). Screening for Life: Perspectives From Adult Metabolic Specialists on Newborn Screening for Inherited Metabolic Diseases. Journal of Inherited Metabolic Disease. 48(4). e70057–e70057. 1 indexed citations
4.
Jaeger, Bregje, Mirjam Langeveld, Robert Brunkhorst, et al.. (2024). Riboflavin transporter deficiency in young adults unmasked by dietary changes. JIMD Reports. 65(4). 233–238. 1 indexed citations
5.
Dussen, Laura van, et al.. (2024). Establishing Treatment Effectiveness in Fabry Disease: Observation-Based Recommendations for Improvement. International Journal of Molecular Sciences. 25(17). 9752–9752. 4 indexed citations
6.
Veldwijk, Jorien, et al.. (2024). Different diseases, different needs: Patient preferences for gene therapy in lysosomal storage disorders, a probabilistic threshold technique survey. Orphanet Journal of Rare Diseases. 19(1). 367–367. 1 indexed citations
7.
Jaeger, Bregje, et al.. (2024). Riboflavin transporter deficiency, the search for the undiagnosed: a retrospective data mining study. Orphanet Journal of Rare Diseases. 19(1). 410–410.
8.
Klouwer, Femke C. C., Stefan D. Roosendaal, Carla E. M. Hollak, et al.. (2024). Redefining the phenotype of alpha-methylacyl-CoA racemase (AMACR) deficiency. Orphanet Journal of Rare Diseases. 19(1). 350–350. 3 indexed citations
9.
Dijk, Tessa van, et al.. (2023). A qualitative study on the perspectives of mothers who had been diagnosed with primary carnitine deficiency through newborn screening of their child. Orphanet Journal of Rare Diseases. 18(1). 134–134. 1 indexed citations
10.
Ferdinandusse, Sacha, Saskia N. van der Crabben, Eugènie Dekkers, et al.. (2023). Newborn screening for primary carnitine deficiency: who will benefit? – a retrospective cohort study. Journal of Medical Genetics. 60(12). 1177–1185. 7 indexed citations
11.
Davids, Mark, et al.. (2021). Differences in faecal microbiome composition between adult patients with UCD and PKU and healthy control subjects. Molecular Genetics and Metabolism Reports. 29. 100794–100794. 9 indexed citations
12.
Knottnerus, Suzan J. G., Henk Schierbeek, Jeannette C. Bleeker, et al.. (2020). Exploring the metabolic fate of medium-chain triglycerides in healthy individuals using a stable isotope tracer. Clinical Nutrition. 40(3). 1396–1404. 11 indexed citations
13.
Dussen, Laura van, André B. P. Kuilenburg, Marcel G. W. Dijkgraaf, et al.. (2020). Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease. International Journal of Molecular Sciences. 21(16). 5784–5784. 51 indexed citations
14.
Mankowski, Robert T., et al.. (2016). Management of an LCHADD Patient During Pregnancy and High Intensity Exercise. JIMD Reports. 32. 95–100. 11 indexed citations
15.
Langeveld, Mirjam, et al.. (2013). [The mediocre results of dieting].. PubMed. 157(29). A6017–A6017. 11 indexed citations
16.
Langeveld, Mirjam, et al.. (2013). Het magere resultaat van diëten. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 157(29).
17.
Langeveld, Mirjam & Johannes M. F. G. Aerts. (2009). Glycosphingolipids and insulin resistance. Progress in Lipid Research. 48(3-4). 196–205. 100 indexed citations
18.
Vlugt, Karen Ghauharali‐van der, et al.. (2008). Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease. Clinica Chimica Acta. 389(1-2). 109–113. 61 indexed citations
19.
Langeveld, Mirjam, Saskia Scheij, Peter F. Dubbelhuis, et al.. (2007). Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemia. Metabolism. 56(3). 314–319. 17 indexed citations
20.
Langeveld, Mirjam, Laila E. Gamadia, & Ineke J. M. ten Berge. (2006). T‐lymphocyte subset distribution in human spleen. European Journal of Clinical Investigation. 36(4). 250–256. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim Wood Breakdown of academic impact, for papers by Klary E. Niezen‐Koning Breakdown of academic impact, for papers by Enzo Ranieri Breakdown of academic impact, for papers by Adolf Mühl Breakdown of academic impact, for papers by Haruo Shintaku Breakdown of academic impact, for papers by Amel Karaa Breakdown of academic impact, for papers by Joe T.R. Clarke Breakdown of academic impact, for papers by Misao Ōwada Breakdown of academic impact, for papers by Klaus Gempel Breakdown of academic impact, for papers by Deborah Marsden
Rankless by CCL
2026